Clinical trial

Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly…

NCT00002827 · Children's Oncology Group, Other · Completed

Key facts

NCT number NCT00002827
Title Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease
Official title RESPONSE DEPENDENT TREATMENT OF STAGES IA, IIA AND IIIA HODGKIN'S DISEASE WITH DBVE AND LOW DOSE INVOLVED FIELD IRRADIATION WITH OR WITHOUT ZINECARD: A PEDIATRIC ONCOLOGY GROUP PHASE III STUDY
Lead sponsor Children's Oncology Group, Other
Collaborators National Cancer Institute (NCI) NIH Children's Cancer Group
Status Completed
Phase Phase 3
Study type Interventional
Conditions Cardiac Toxicity, Lymphoma
Intervention type Biological, Drug, Radiation
Interventions bleomycin sulfate, filgrastim, dexrazoxane hydrochloride, doxorubicin hydrochloride, etoposide, vincristine sulfate, low-LET cobalt-60 gamma ray therapy, low-LET electron therapy, low-LET photon therapy
Enrollment 294
Start date Oct 1, 1996
Primary completion Oct 1, 2004
Completion Jun 1, 2008
First posted May 26, 2004
Last update posted Aug 26, 2013
Countries Australia, Canada, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies